AWHL Aspira Women's Health Inc.

BULLISH Impact: 5/10 Insider Cluster (2 insiders)
Horizon weeks Filed May 29, 2026 Processed 22d 11h ago
Insider cluster: 2 insiders, $32K total
Latest settled — T+5d
AWHL ▼ -22.22% at T+5d
LONG call ✗ call lost -22.22% · α vs SPY -19.47% · entry $0.5400 → $0.4200
Next anchor: T+20d in 8d
Last close $0.5200 (close Jun 17) · -3.70% from $0.5400 entry
Entry anchored
May 29, 2026
via day open
T+1d
0.00%
call 0.00% · α -0.14%
$0.5400
settled 20d ago
T+5d
-22.22%
call -22.22% · α -19.47%
$0.4200
settled 16d ago
T+20d
call — · α —
in 8d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Two directors at Aspira Women's Health purchased a total of $32K in shares on the same day at $0.45/share, three days after the company announced a collaboration agreement with Cleveland Clinic. The cluster is small relative to market cap but is amplified by the cross-filing context of a material agreement, suggesting insiders may have been informed of the deal's strategic value.

Key Financial Metrics

Direction
buying
Total Value
$32.0K
Insiders
2

Actionable Insight

While the dollar amount is small, the timing — three days after a strategic collaboration with Cleveland Clinic — suggests insider conviction in the deal's value. Monitor for additional insider buying, especially from C-suite, and for any material terms from the collaboration's Statements of Work.

Key Facts

  • Two directors purchased 72K shares total for $32K at $0.45/share on 2025-09-17
  • Purchases occurred 3 days after the 8-K filing of a Master Collaboration and License Agreement with Cleveland Clinic
  • Total value of $32K is approximately 0.01% of market cap (assuming ~$326M market cap), below the 0.1% materiality threshold
  • Both trades are open-market purchases (code P), not grants or tax withholdings
  • No C-suite executives participated in the cluster

Financial Impact

Insider purchases total $32K, a trivial amount relative to market cap

insider ownership

Risk Factors

  • Small dollar amount relative to market cap limits signal strength
  • No C-suite participation reduces informational value of the cluster
  • OTC listing may amplify volatility and reduce liquidity

Market Snapshot

Exchange
OTC
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
80% bullish (5 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-AWHL-1780085283043
5 reports for AWHL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AWHL — sortable, filterable
Type Now
Jun 9, 2026
11d ago
8-K
BEARISH ★ 6/10
$0.4300 $0.5000▼ −16.28%▼ −14.48%$0.5200 (−20.93%)
May 29, 2026
22d ago
Insider Cluster
BULLISH ★ 5/10
$0.5400 $0.4200▼ −22.22%▼ −19.47%$0.5200 (−3.70%)
May 26, 2026
25d ago
8-K
NEUTRAL ★ 4/10
$0.4600 $0.5400▲ +17.39%▲ +16.31%$0.5200 (+13.04%)
Apr 30, 2026
7w ago
8-K
NEUTRAL ★ 3/10
$0.3900 $0.4300▲ +10.26%▲ +7.91%$0.5200 (+33.33%)
Apr 28, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$0.4000 $0.3900▼ −2.50%▼ −5.61%$0.5200 (+30.00%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (29h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access